What is New in Neuro-oncology?
Brain tumor classification
Immune therapy
Neuro-oncology update
Targeted therapy
Journal
Neurologic clinics
ISSN: 1557-9875
Titre abrégé: Neurol Clin
Pays: United States
ID NLM: 8219232
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
entrez:
23
11
2020
pubmed:
24
11
2020
medline:
23
3
2021
Statut:
ppublish
Résumé
Neuro-oncology is a rapidly developing field. A continuous evolution in the understanding of the molecular underpinnings of central nervous system tumors has helped reconfigure the classification of brain tumors. More importantly, it has laid the path forward for the development and investigation of new therapeutics. The authors discuss the classification of brain tumors and novel therapies in brain tumors as well as promising treatments underway.
Identifiants
pubmed: 33223081
pii: S0733-8619(20)30076-1
doi: 10.1016/j.ncl.2020.09.009
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
163-179Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure Jigisha Thakkar and Vikram Prabhu have no disclosures. Katherine Peters: Advisory board: Agios, Bayer Research support: Agios, Novocure. Rimas Lukas: Honoraria for consulting for Abbvie, Eisai. Honoraria for advisory board Monteris. Honoraria for medical editing Medlink Neurology, EBSCO Publishing.